1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Differential expression of full-length and NH2 terminally truncated FAM134B isoforms in normal physiology and cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Comparative tissue distribution and depuration characteristics of copper nanoparticles and soluble copper in rainbow trout (Oncorhynchus mykiss)
(
- Contribution to journal › Article
- 2018
-
Mark
Radiosynthesis, biological evaluation and preliminary microPET study of 18F-labeled 5-resorcinolic triazolone derivative based on ganetespib targeting HSP90
(
- Contribution to journal › Article
- 2016
-
Mark
Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules
(
- Contribution to journal › Article
- 2014
-
Mark
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule
(
- Contribution to journal › Article
-
Mark
Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde
(
- Contribution to journal › Article
- 2013
-
Mark
Which prior knowledge? : Quantification of in vivo brain 13C MR spectra following 13C glucose infusion using AMARES
(
- Contribution to journal › Article
-
Mark
Influence of nuclides and chelators on imaging using affibody molecules : comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA
(
- Contribution to journal › Article
-
Mark
HAHAHA, HEHEHE, HIHIHI, or HKHKHK : influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules
(
- Contribution to journal › Article
- 2012
-
Mark
Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules
(
- Contribution to journal › Article